many serious systemic fungal infections. Its application has increased during the past decade for the treatment Objective: To evaluate the effects of four types of inof several fungal infections accompanied by organ and line filters on filtration rate, amphotericin B contissue transplantation, intensive chemotherapy and centration and particulate matter.
INTRODUCTION
recommended for preparing intravenous amphotericin B infusion at pHs greater than 4·2, and supplemented Amphotericin B, an amphipathic polyene macrolide fluid at pH 6·5 and 5·6 passed easily through 0·45 or derived from Streptomyces nodosus, is widely used for 1·0 m filter, respectively (12) . Filtration with a 0·22 m filter substantially decreased the concentrations of amCorrespondence: Yasufumi Kataoka. Tel: + 81 92 642 5920; fax: + 81 92 642 5937; e-mail: ykataoka@st.hosp.kyushu-u.ac.jp photericin B in the infusion, even at pH 6·5, several hours after filtration (12) . Therefore, filters larger than 5% dextrose for injection (500 ml; Otsuka, Lot No.; K8A77) and sterile water for injection (20 ml; Otsuka, 1 m are recommended for the filtration of amphotericin B fluid (15) . This recommendation needs to be Japan, Lot No.; K7G80). All remaining reagents were analytical grade and were purchased from Wako Pure reevaluated, as various new types of in-line filters have been recently developed. Based on the limit Chemical Industries (Osaka, Japan). The in-line filters used are shown in Table 1 . An intravenous addefined by United States Pharmacopoeia (USP XXIII), there should be less than 25 particles/ml of particulate ministration set (Terufusion, Terumo Co. Ltd, Japan, Lot No.; 971020D1) was also used. matter larger than 10 m in large volume injections (16). We have reported that particulate matter in nonfiltered amphotericin B fluid was over this limit (40·8±7·0 particles/ml, n=3) when amphotericin B Preparation of standard solution was reconstituted with 10 ml of sterile water and 5% dextrose (50 mg/500 ml) (17). The filtration of the reOne vial of amphotericin B for infusion was reconstituted amphotericin B injection through a 0·2 m constituted with 10 ml of sterile water and shaken for polyethersulphone (PES) membrane filter before an 5 min with a shaker (original amphotericin B solution: addition of 5% dextrose significantly decreased par-50 mg/10 ml). One ml of this solution was diluted ticulate matter in the final solution by 64% without with 9 ml of 5% dextrose injection and then further loss of amphotericin B (17). In the present study, we dilutions (2·5, 5, 10, 20, 40, 60 and 100 g/ml) were examined the effects of various in-line final filters on made with 5% dextrose injection for the calibration of the flow rate of intravenous amphotericin B fluid and the MEKC assay. the concentration of amphotericin B in the filtered fluid using micellar electrokinetic capillary chromatography (MEKC). Particle size in amphotericin B fluid after filtration was also measured.
Preparation of samples

Flow rate of amphotericin B fluid during filtration
MATERIALS AND METHODS
Based on the intended clinical application, either 4 or 10 ml of the original amphotericin B solution was Chemicals and in-line filters added to 500 ml infusion vials of 5% dextrose to make 40 or 100 g/ml amphotericin B concentrations. The The chemicals used were as follows: amphotericin B for infusion (50 mg Fungizone⊂ injection, imported by fluid reservoir was hung 90 cm above the filter and intravenous fluid was dripped through in-line final Bristol-Myers Squibb, Tokyo, Japan, Lot No.; FZV1180), filters under maximum gravity flow. The volume of filtered fluid was measured every 10 min during filtration.
Concentrations of amphotericin B in the filtered fluid
Five bottles of intravenous amphotericin B fluids (40 g/ml, 500 ml) were dripped through each in-line filter at an initial flow rate of 500 ml/24 h. One bottle was allowed to drip without filter as a control. One ml was sampled from the original bottle at the start of filtration (0 h). One ml was sampled directly from post-filtered fluid at 1, 2, 4, 8, 12, 18 and 24 h after the start of filtration. One ml was also sampled from the pooled fluid collected for 24 h after the start of filtration. Each sample (1 ml) was diluted with 5% dex- measured with a PMS counter as described previously (19) . In brief, the PMS system consisted of an APSS-200 counter connected to a LiQuilaz-E20 sensor with a laser diode (121 mW, 780 nm) and automatic bottle MEKC assays of amphotericin B sampler, LS-200 (Particle Measuring Systems Inc., Boulder, CO, U.S.A.). The mean level of triplicate Amphotericin B concentrations in pharmaceutical sodeterminations was calculated. lutions were measured by the MEKC method, as described previously (17). MEKC assays, one type of capillary electrophoresis (CE), were performed on an HP3D system with a diode-array UV detector
RESULTS AND DISCUSSION
(Hewlett-Packard, Waldbronn, Germany). In all experiments, a constant voltage of 30 kV was applied, Changes in the flow rate of amphotericin B fluid the temperature was set at 25°C and detection was made at 407 nm. A silica-fused extended light path The pH of each intravenous amphotericin B fluid (40 and 100 g/ml) was within that necessary for a stable capillary (64·5 cm × 75 m i.d., Hewlett-Packard) was used for all MEKC separations (18). The composition colloidal solution (pH 6·7 and 7·0, respectively; n= 1). The volumes of intravenous amphotericin B fluid of the electrophoresis running buffer was 10 mm phosphate buffer (pH 8·8) with 25 mm SDS. A sample was (40 g/ml) filtered through various in-line filters under maximum gravity flow are shown in Fig. 1 . Without injected into the capillary with the vacuum system at 50 mmHg for 5 s. The mean of triplicate determinations an in-line filter, 500 ml amphotericin B fluid emptied completely within 20 min (control). Filtration through was calculated. 0·2 m PES filters did not (each filter tested once, Fig. 2 ). Flow rate inhibition by the 0·2 m positively The 0·2 m positively charged nylon 66 and 0·2 m nylon 66 filter took 70 and 100 min, respectively, to charged nylon 66 filter was highest. These flow rates are close to those obtained with the maximum gravity filter 500 ml of amphotericin B fluid (Fig. 1) . Tests using amphotericin B fluid (100 g/ml) were very flow experiments. This simple and time-saving experiment may be enough to estimate the effects of similar.
In experiments where the flow rate was initially set filters on flow rate of various intravenous fluids. The 1·2 m and 0·2 m PES filters are more suitable for use to 500 ml/24 h, the 0·2 m positively charged nylon 66 and the 0·2 m nylon 66 filters decreased the flow rate than the 0·2 m positively charged nylon 66 and the 0·2 m nylon 66 filters in terms of flow rate. by 20 and 50%, respectively, but the 1·2 m or the
Changes in amphotericin B concentrations of the filtered intravenous fluid
The concentrations of amphotericin B in the intravenous fluid were measured after filtration with various filters (Fig. 2) . The flow rate was set at 500 ml/ 24 h before the start of filtration. The 0·2 m nylon 66 filter gradually decreased the concentration of amphotericin B to 47·1±35·7% and 65·8±34·7% at 18 and 24 h after the start of filtration, respectively. The 0·2 m positively charged nylon 66 filter rapidly decreased amphotericin B concentrations to undetectable levels within 1 h; this event was accompanied by a slow filtration rate. The 1·2 m and 0·2 m PES filter did not influence amphotericin B concentrations in fluid filtered at each period during filtration or on the final pooled fluid filtered for 24 h [ Fig. 2 (40 g/ml) and Fig. 3 (100 g/ml)]. Positively charged nylon 66 filters have amide linkages in the linear polymer and adsorb negatively charged substances such as pyrogens, bacteria, virus and colloidal materials from solutions (8) . This type of filter is inappropriate for filtration of amphotericin B fluid because it adsorbs micellar amphotericin B/DOC complex and slowly becomes clogged. PES is less adsorptive and is particularly useful for filtration of protein products (8, 20) . Filtration through PES membranes produces fewer conformational changes in proteins compared to nylon membranes (21). Although the bioactivity of amphotericin B fluid filtered through PES filter was not examined, the CE spectrum of amphotericin B was not Figure 4 shows the numbers of particles larger than intravenous amphotericin B fluid at pH higher than 4·2. Five percent dextrose for injection was reported 10 m in preparations of intravenous amphotericin B fluid filtered through 0·2 m or 1·2 m PES filters.
Particulate matter
by the manufacturer to have a pH of around 4·8, but the pH of the 5% dextrose for injection used here was Based on the limit defined by United States Pharmacopoeia (USP XXIII), there should be fewer than 25 4·6 (n=1). These results indicate that 1·2 m and 0·2 m PES filters can be used to filter intravenous amparticles/ml of particles larger than 10 m in large volume injections. Particulate matter in the non-filtered photericin B fluid prepared with 5% dextrose at pH greater than 4·2 and remove the larger particles from intravenous amphotericin B fluid before filtration was 27±5 particles/ml (Fig. 3) . The 1·2 m and 0·2 m PES the fluid. In-line filter membranes no greater than 0·2 m size are required to minimize the risk of infilter significantly decreased particulate matter by 83 and 97%, respectively, after filtration (Fig. 3) . Dextrose fection in patients during the administration of intravenous fluids (9-11). Therefore, we recommend 0·2 m is recommended for preparing the stable colloidal
